Tag: FDA

CHC_FDA-Regulatory Images1

07/31/2018

FDA Cracks Down on Deceptive Claims for “Vaginal Rejuvenation” Procedures

CHC_Legislative1

06/13/2018

Azar Says FDA Has Authority to Require List Prices in Drug Ads

CHC_general2

05/29/2018

Rawson Shares Short- and Long-term Drug Pricing Fallout at CHC Meeting

News-Jon Bigelow

05/14/2018

Gain Actionable Insights at Rising Leaders Conference on Healthcare Policy

CHC_general1

05/04/2018

White House Drug Pricing Initiative Could Include Moves on Generics/Biosimilars, Demonstration Projects and an End to Part D Rebates, Rawson Says

CHC_general2

03/26/2018

FDA Announces Mobile App to Help Consumers Get Drug Info

CHC_offLabel

12/22/2017

FDA To Study Consumer, HCP Ability to Spot Deceptive Drug Ads

CHC_FDA-Regulatory Images1

12/15/2017

FDA Finalizes Guidance on Name Placement, Size and Prominence

CHC_FDA-Regulatory Images1

11/30/2017

OPDP’s Third Enforcement Letter of 2017 Cites Presentation of Risks, Efficacy Claims